2 completed. 2 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
Follow Viusid: new trials by email Literature Review of Viusid trials Research Report on Viusid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of Treatment With Viusid in Post-COVID-19 Syndrome Viusid Oral Solution, Placebo - Post-COVID-19 Syndrome, COVID-19 | Not applicable | Completed | Catalysis SL | 200 | 2022-02-15 | 2024-06-03 |
| Evaluation of the Effectiveness of Therapy for Patients With Covid-19 Using Food Supplements Viusid + Asbrip Viusid and Asbrip, COVID-19 Standard Therapy - Covid19, COVID-19 Pneumonia | Not applicable | Completed | Catalysis SL | 80 | 2021-01-08 | 2022-04-13 |
COVID-19 (2) · Coronavirus Infections (1) · Cough (1) · Dyspnea (1) · Fatigue (1) · Inflammation (1) · Post-Acute COVID-19 Syndrome (1) · Respiratory Tract Infections (1) · Virus Diseases (1)
Catalysis SL (2)
Colombia (1) · Kazakhstan (1)